CRWD vs TMO: Which Is the Better Buy?
Side-by-side comparison of CrowdStrike Holdings, Inc. and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-07-09.
CrowdStrike Holdings, Inc. · Technology
$191.12
+32.7% upside to fair value
Grade B
VS
Thermo Fisher Scientific Inc. · Healthcare
$464.61
+7.2% upside to fair value
Grade A
High Quality
QuantHub Verdict
CRWD has more upside to fair value
(+32.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
CRWD |
TMO |
| Current Price |
$191.12 |
$464.61 |
| Fair Value Estimate |
$253.64 |
$498.27 |
| Upside to Fair Value |
+32.7%
|
+7.2%
|
| Market Cap |
$194.6B |
$172.7B |
| Forward P/E |
-4023.6x
|
25.2x
|
| EV / EBITDA |
570.3x
|
19.1x
|
| Price / Sales |
38.2x
|
3.8x
|
| Price / FCF |
134.0x
|
25.6x
|
| Revenue Growth YoY |
+25.6%
|
+6.2%
|
| Gross Margin |
75.0%
|
39.4%
|
| Operating Margin |
-3.9%
|
17.8%
|
| Return on Equity |
-0.6%
|
13.3%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.75%
|
3.91%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
CrowdStrike Holdings, Inc. operates in the technology sector, specifically in software infrastructure, providing cybersecurity solutions. The business quality is medium due to its strong revenue growth of 25.6% in the most recent quarter and impressive earnings growth of 125.2% in the same period, indicating effective scaling and operational leverage. However, profitability metrics remain challen…
Thermo Fisher Scientific is a leading healthcare company specializing in life science tools, diagnostics, and contract research and manufacturing services. It operates with a broad, multi-layered moat driven by scale, integration, and a long-tenured management team. The company exhibits solid fundamentals with a 13.3% ROE, 6.2% revenue growth, and 9.6% earnings growth in the most recent quarter. …
Accumulation Zones
| Metric |
CRWD |
TMO |
| Zone Low |
$190.23 |
$373.70 |
| Zone High |
$215.59 |
$423.53 |
| In Buy Zone? |
Yes
|
No
|